Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

AbbVie doubles down on immunology with US$ 2.1 bn Capstan buyout; India's Torrent buys controlling stake in JB Chem

This week in Phispers, AbbVie struck a deal worth up to US$ 2.1 billion to acquire Capstan Therapeutics and its innovative in v...

Impressions : 574

Royalty Pharma inks US$ 2 bn cancer drug deal with Revolution; Astra-Daiichi's Datroway wins US approval for lung cancer

In news this week, Royalty Pharma committed up to US$ 2 billion to Revolution Medicines for their promising pancreatic and lung...

Impressions : 2883

Lilly acquires gene-editing firm Verve for US$ 1.3 bn, BioNTech buys CureVac; Astra signs US$ 5.3 bn AI deal with China's CSPC

This week’s Phispers comes with news on several M&A deals. Eli Lilly made headlines with its US$ 1.3 billion acquisition ...

Impressions : 564

RFK Jr fires all 17 members of CDC's vaccine committee; Merck's oral cholesterol drug meets goals in late-stage trials

This week, US Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. dismissed all 17 members of the US Centers for D...

Impressions : 1053

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

AbbVie doubles down on immunology with US$ 2.1 bn Capstan buyout; India's Torrent buys controlling stake in JB Chem

Royalty Pharma inks US$ 2 bn cancer drug deal with Revolution; Astra-Daiichi's Datroway wins US approval for lung cancer

Lilly acquires gene-editing firm Verve for US$ 1.3 bn, BioNTech buys CureVac; Astra signs US$ 5.3 bn AI deal with China's CSPC

RFK Jr fires all 17 members of CDC's vaccine committee; Merck's oral cholesterol drug meets goals in late-stage trials

Regeneron's Biologics Lynozyfic Receive Approval in US

Eli Lilly's Biologics Kisunla Receive Suppl Approval in US

BMS's Biologics Opdivo Receive Suppl Approval in US

Annora Pharma's Generics Prucalopride Receives Approval in US

Aggrega's Generics Prucalopride Receives Approval in US

H2-Pharma's Generics Prucalopride Receives Approval in US

Unique's Generics Alcohol Receives Approval in US

Unique's Generics Amitriptyline HCl Receives Approval in US

Torrent's Generics Apremilast Receives Approval in US

GSK's Biologics Benlysta Receives Suppl Approval in US

Enforcement Report - Week of July 2, 2025

Staska Pharmaceuticals Recieves Warning Letter

Sandoz Issues a Nationwide Recall of Cefazolin

Enforcement Report - Week of June 25, 2025

Zhejiang Medicinel is on Health Canada Inspection List

Yiling Pharmaceutical is on Health Canada Inspection List

Emix Limited's Fails EDQM inspection

Enforcement Report - Week of June 18, 2025

Huahai Pharma Recieves Warning Letter

Kenil Healthcare Recieves Warning Letter

FDA grants fast track to Duke Street Bio's PARP1-selective

OneSource Specialty Pharma appoints Jeffrey Wong as CBO

Aster DM Healthcare Targets Smaller Cities to Expand

Mounjaro Hits Rs 50 Cr Milestone in India as Wegovy Enters Market

Sun Pharma Works to Resolve USFDA Issues at 3 Plants

Lobe Science Validates EU Patent for DHA Combo in Sickle Cell

Boehringer Ingelheim starts Phase II study of BI 1815368

Cogent's Bezuclastinib Hits All Endpoints in SUMMIT Trial

Basilea gets USD 39M BARDA funding for antifungals fosmanogepix

India, Uzbekistan Aim for Strategic Pharma Collaboration

Akash Kedia Warns of Us Pricing Reform Impact on Indian Pharma

Dr Raj Nagarkar discusses acute shortages in Indian healthcare

Lupin Gets FDA nod for Loteprednol Etabonate Ophthalmic Gel

FDA Confirms Para IV Patent Litigation for Veklury Powder for Inj

Asahi Kasei Pharma Begins Phase III Study on Cipn Prevention

Cadila Pharmaceuticals launches Bilacad Dex Syrup

Pharmexcil Talks with US on Trade Facilitation, Market Access

Europe Must Restore Generic Manufacturing Autonomy: Teva Exec

Alembic Gets US FDA Approval for Doxorubicin Liposome

Alembic Announces USFDA Final Approval for Single-Dose Vials

OneSource Specialty Pharma appoints Jeffrey Wong as CBO

Boehringer Ingelheim starts Phase II study of BI 1815368

Cogent's Bezuclastinib Hits All Endpoints in SUMMIT Trial

NPPA Notifies Retail Prices of 71 Formulations

Provider groups sue RFK Jr. to Roll back COVID-19 Vaccine Policy

Chugai & Gero Enter into Agreement for Age-Related Diseases

SPARC incorporates subsidiary 'Genokine Biotech'

Spain and UK Validate Godavari Biorefineries' Anti-Cancer Patent

Applied DNA Complies with All Nasdaq Listing Requirements

Cogent Hits Primary Endpoint, Building Case for Blueprint Rival

Nectar to Sell Api, Formulation & Menthol Biz to Ceph Lifescience

BioNxt readies Sublingual Cladribine Program for MS Phase

Axplora Doubles Farmabios Footprint with €35M Expansion

BDMA to review Sigachi Pharma explosion in Hyderabad: RK Agarwal

Axcelead, A2 Healthcare Partner to Accelerate Drug R&D

Nippon Shokubai to Expand Nucleic Acid API Capacity 10x

DBT to Support Biomanufacturing of APIs to reduce GHG emissions

Sigachi Gets ToR Approval For API & Chemicals Manufacturing

Zydus gets EIR for API facility at Ankleshwar & Dabhasa

India Must Enhance Role as Global Supply Chain Innovator

Sun Pharma Works to Resolve USFDA Issues at 3 Plants

China Retaliates with Import Restrictions on Medical Devices

Sigachi Updates on Fire at Pashamylaram Telangana Plant

Pharma Industry Seeks Secure Graphics, Data Protection Against

Indian Healthcare Grapples with Illegible Prescriptions

Govt to Bring in Barcodes to Fight Fake Drug Menace

Plans to Restrict Open Market Access to Tuberculosis Medicines

Aurobindo Pharma recalls 4,608 pain reliever bottles in US

CDC Panel Recommends Against Use of Thimerosal in Flu Vaccines

Pondicherry Pharma MSMEs Face Deadline in CDSCO's cGmp Crackdown

Aster DM Healthcare Targets Smaller Cities to Expand

India, Uzbekistan Aim for Strategic Pharma Collaboration

DoC Reviews Key Export, Import Issues with Stakeholders, Trade